- ДокументJDRF Therapeutic Venturesзагружено:sstrumello7395
- ДокументGeneral Foods Corporate Timelineзагружено:sstrumello7395
- ДокументJDRF, Less Until Noneзагружено:sstrumello7395
- ДокументWhy Big Pharmaceutical Companies’ Current Nanotech Efforts Should Failзагружено:sstrumello7395
- ДокументNovo Nordisk Congressional Testimony on Follow-On Biopharmaceuticals Mollerup March 26, 2007загружено:sstrumello7395
- ДокументEmblem Insulin Formulary Change 2010загружено:sstrumello7395
- ДокументWhy Nonprofits Fund For-Profit Companies Doing Drug Researchзагружено:sstrumello7395
- ДокументAgaMatrix & Sanofi-Aventis Enter Global Diabetes Partnershipзагружено:sstrumello7395
- ДокументHuman insulin prepared by recombinant DNA techniques and native human insulin interact identically with insulin receptorsзагружено:sstrumello7395
- ДокументFDA ISO Standards for BG Meters 06-24-2009загружено:sstrumello7395
- ДокументBeyond 'I'm a Diabetic', Little Common Groundзагружено:sstrumello7395
- ДокументHalozyme Therapeutics, Inc. 2009 Investor Day Presentationзагружено:sstrumello7395
- ДокументJDRF Countdown July 2009загружено:sstrumello7395
- Документ2008-03-24_Asset_EN Paper on Follow-On Biologics Jan. 2007загружено:sstrumello7395
- Документ2008-03-24_Asset_PCMA Summary of en Studyзагружено:sstrumello7395
- ДокументInfluence of insulin antibodies on pharmacokinetics and bioavailability of recombinant human and highly purified beef insulins in insulin dependent diabeticsзагружено:sstrumello7395
- ДокументThe Unique Cytoarchitechture of Human Pancreatic Islets Has Implications for Islet Cell Functionзагружено:sstrumello7395
- ДокументStatement of Inger Mollerup, VP Novo Nordisk A/S for Congressional Hearings on "Follow-On Biopharmaceuticals"загружено:sstrumello7395
- ДокументMost Commercial Insulin Assays Fail to Detect Recombinant Insulin Analoguesзагружено:sstrumello7395
- ДокументHow Do We Define Cure of Diabetes?загружено:sstrumello7395
- ДокументExpanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin isotopeзагружено:sstrumello7395
- ДокументCould Generic Insulin Soon Hit the U.S. Market?загружено:sstrumello7395
- ДокументClass Action Complaint for Negligence, Products Liability and Punitive Damages Against Eli Lilly & Company and Novo Nordisk A/S Re; Biosynthetic Human Insulinзагружено:sstrumello7395
- ДокументMandated Diabetes Registries Will Not Benefit Persons With Diabetesзагружено:sstrumello7395
- ДокументDetermination of Purity and Identification of Animal Sources of Insulin in Various Insulin Preparationsзагружено:sstrumello7395
- ДокументPeter Van Etten JDRF Letter Reзагружено:sstrumello7395
- ДокументTreatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 yearsзагружено:sstrumello7395
- ДокументDifferent Potencies of Biosynthetic Human and Purified Porcine Insulinзагружено:sstrumello7395
- ДокументQuestions Answers &загружено:sstrumello7395
- ДокументStem Cells and Diabetesзагружено:sstrumello7395
- ДокументFederal Funding of Stem Cell Researchзагружено:sstrumello7395